Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Functions of Metallothionein Generating Interleukin-10-Producing Regulatory $CD4^{+}T$ Cells Potentiate Suppression of Collagen-Induced Arthritis

  • Huh, Sung-Jin (Department of Anatomy and Cell Biology) ;
  • Lee, Kyu-Heon (Department of Biomedical Sciences and Institute of Biomedical Sciences, Hanyang University) ;
  • Yun, Hye-Sun (Department of Anatomy and Cell Biology) ;
  • Paik, Doo-Jin (Department of Anatomy and Cell Biology) ;
  • Kim, Jung-Mogg (Department of Microbiology, College of Medicine, Hanyang University) ;
  • Youn, Jee-Hee (Department of Anatomy and Cell Biology)
  • Published : 2007.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Metallothionein, a cysteine-rich stress response protein that is naturally induced by a variety of immunologic stressors, has been shown to suppress autoimmune disorders through mechanisms not yet fully defined. In the present study, we examined the underlying mechanisms by which metallothionein might mediate such regulation of autoimmunity. $Na\ddot{i}ve\;CD4^+$ T cells from metallothionein-deficient mice differentiated to produce significantly less IL-10, $TGF-{\gamma}$, and repressor of GATA, but more $IFN-{\gamma}$ and T-bet, when compared with those from wild-type mice. The levels of IL-4 and GATA-3 production were not different between the two groups of mice. Conversely, treatment with exogenous metallothionein during the priming phase drove $na\ddot{i}ve$ wild-type $CD4^+\;T$ cells to differentiate into cells producing more IL-10 and $TGF-{\beta}$, but less $IFN-{\gamma}$ than untreated cells. Metallothionein-primed cells were hyporesponsive to restimulation, and suppressive to T cell proliferation in an IL-10-dependent manner. Lymphocytes from metallothionein-deficient mice displayed significantly elevated levels of AP-1 and JNK activities in response to stimulation compared with those from wild-type controls. Importantly, transgenic mice overexpressing metallothionein exhibited significantly reduced susceptibility to collagen-induced arthritis and enhanced IL-10 level in the serum, relative to their nontransgenic littermates. Taken together, these data suggest that metallothionein is able to promote the generation of IL-10-and $TGF-{\beta}$-producing type 1 regulatory T-like cells by downregulating JNK-dependent AP-1 activity. Thus, metallothionein may play an important role in the regulation of Th1-dependent autoimmune arthritis, and may represent both a potential target for therapeutic manipulation and a critical element in the diagnostic assessment of disease potential.

Keywords

References

  1. Abdel-Mageed, A. B. and K. C. Agrawal. 1998. Activation of nuclear factor kappaB: Potential role in metallothioneinmediated mitogenic response. Cancer Res. 58: 2335-2338
  2. Akasaki, Y., G. Liu, N. H. Chung, M. Ehtesham, K. L. Black, and J. S. Yu. 2004. Induction of a $CD4^{+}$ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J. Immunol. 173: 4352-4359 https://doi.org/10.4049/jimmunol.173.7.4352
  3. Barrat, F. J., D. J. Cua, A. Boonstra, D. F. Richards, C. Crain, H. F. Savelkoul, R. de Waal-Malefyt, R. L. Coffman, C. M. Hawrylowicz, and A. O'Garra. 2002. In vitro generation of interleukin 10-producing regulatory $CD4^{+}$ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616 https://doi.org/10.1084/jem.20011629
  4. Basu, A. and J. S. Lazo. 1990. A hypothesis regarding the protective role of metallothionein against the toxicity of DNA interactive anticancer drug. Toxicol. Lett. 50: 123- 135 https://doi.org/10.1016/0378-4274(90)90002-4
  5. Bremner, I., R. K. Mehra, and M. Sato. 1987. Metallothionein in blood, bile, and urine. Experientia 52: 507-517
  6. Butcher, H. L., W. A. Kennette, O. Collins, R. K. Zalups, and J. Koropatnick. 2004. Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts. J. Pharmacol. Exp. Ther. 310: 589-598 https://doi.org/10.1124/jpet.104.066126
  7. Chen, C., W. H, Lee, P. Yun, P. Snow, and C. P. Liu. 2003. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J. Immunol. 171: 733-744 https://doi.org/10.4049/jimmunol.171.2.733
  8. Chen, H., E. C. Carlson, L. Pellet, J. T. Moritz, and P. N. Epstein. 2001. Overexpression of metallothionein in pancreatic $\beta$-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 50: 2040-2046 https://doi.org/10.2337/diabetes.50.9.2040
  9. Cobbold, S. P., K. F. Nolan, L. Graca, R. Castejon, A. Le Moine, M. Frewin, S. Humm, E. Adams, S. Thompson, D. Zelenika, A. Paterson, S. Yates, P. J. Fairchild, and H. Waldmann. 2003. Regulatory T cells and dendritic cells in transplantation tolerance: Molecular markers and mechanisms. Immunol. Rev. 196: 109-124 https://doi.org/10.1046/j.1600-065X.2003.00078.x
  10. Coyle, P., J. C. Philcox, and A. M. Rofe. 1995. Metallothionein induction in cultured rat hepatocytes by arthritic rat serum, activated macrophages, interleukin-6, interleukin-1 and leukaemia inhibitory factor. Inflamm. Res. 44: 475-481 https://doi.org/10.1007/BF01837913
  11. Crowthers, K. C., V. Kline, C. Giardina, and M. A. Lynes. 2000. Augmented humoral immune function in metallothioneinnull mice. Toxicol. Appl. Pharmacol. 166: 161-172 https://doi.org/10.1006/taap.2000.8961
  12. Danielson, K. G., S. Ohi, and P. C. Huang. 1982. Immunochemical localization of metallothionein in rat liver and kidney. J. Histochem. Cytochem. 30: 1033-1039 https://doi.org/10.1177/30.10.6752263
  13. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103: 239-252 https://doi.org/10.1016/S0092-8674(00)00116-1
  14. De Lisle, R. C., M. P. Sarras Jr., J. Hidalgo, and G. K. Andrews. 1996. Metallothionein is a component of exocrine pancreas secretion: Implications for zinc homeostasis. Am. J. Physiol. 271: C1103-C1110
  15. Durnam, D. M., J. S. Hoffman, C. J. Quaife, E. P. Benditt, H. Y. Chen, R. L. Brinster, and R. D. Palmiter. 1984. Induction of mouse metallothionein-I mRNA by bacterial endotoxin is independent of metals and glucocorticoid hormones. Proc. Natl. Acad. Sci. USA 81: 1053-1056
  16. El Refaey, H., M. Ebadi, C. A. Kuszynski, J. Sweeney, F. M. Hamada, and A. Hamed. 1997. Identification of metallothionein receptors in human astrocytes. Neurosci. Lett. 231: 131-134 https://doi.org/10.1016/S0304-3940(97)00548-X
  17. Farrar, J. D., M. Ouyang, M. Assenmacher, A. Radbrucher, A. Radbrush, O. Kanagawa, and K. M. Murphy. 2001. An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3. J. Exp. Med. 193: 645- 650
  18. Feng, R., Y. Lu, L. L. Bowman, Y. Qian, V. Castranova, and M. Ding. 2005. Inhibition of activator protein-1, NFkappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 280: 27888-27895 https://doi.org/10.1074/jbc.M503347200
  19. Fiore, F., B. Nuschak, S. Peola, S. Mariani, M. Muraro, M. Foglietta, M. Coscia, B. Bruno, M. Boccadoro, and M. Massaia. 2005. Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells. Eur. J. Immunol. 35: 1155-1163 https://doi.org/10.1002/eji.200425093
  20. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J. E. de Vries, and M. G. Roncarolo. 1997. A $CD4^{+}$ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742 https://doi.org/10.1038/39614
  21. Hamer, D. H. 1986. Metallothionein. Annu. Rev. Biochem. 55: 913-951 https://doi.org/10.1146/annurev.bi.55.070186.004405
  22. Hart, B. A. and J. S. Garvey. 1986. Detection of metallothionein in bronchoalveolar cells and lavage fluid following repeated cadmium inhalation. Environ. Res. 40: 391-398 https://doi.org/10.1016/S0013-9351(86)80114-1
  23. Kawasaki, H., Y. Nakata, G. Suzuki, K. Chihara, T. Tokuhisa, and S. Shiozawa. 1999. Increased c-Fos/activator protein-1 confers resistance against anergy induction on antigen-specific T cell. Int. Immunol. 11: 1873-1880 https://doi.org/10.1093/intimm/11.12.1873
  24. Kemper, C., A. C. Chan, J. M. Green, K. A. Brett, K. M. Murphy, and J. P. Atkinson. 2003. Activation of human $CD4^{+}$ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392 https://doi.org/10.1038/nature01315
  25. Kim, D. S., H. R. Kim, E. R. Woo, S. T. Hong, H. J. Chae, and S. W. Chae. 2005. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem. Pharmacol. 70: 1066-1078 https://doi.org/10.1016/j.bcp.2005.06.026
  26. Kim, I. S., H. S. Yun, H. Shimisu, E. Kitagawa, H. Iwahashi, and I. Jin. 2005. Elucidation of copper and asparagine transport systems in Saccharomyces cerevisiae KNU5377 through genome-wide transcriptional analysis. J. Microbiol. Biotechnol. 15: 1240-1249
  27. Kim, N. and G. E. Ji. 2006. Modulatory activity of Bifidobacterium sp. BGN4 cell fractions on immune cells. J. Microbiol. Biotechnol. 16: 584-589
  28. Kim, W. U., W. K. Lee, J. W. Ryoo, S. H. Kim, J. Kim, J. Youn, S. Y. Min, E. Y. Bae, S. Y. Hwang, S. H. Park, C. S. Cho, J. S. Park, and H. Y. Kim. 2002. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: A novel treatment strategy for induction of oral tolerance. Arthritis Rheum. 46: 1109-1120 https://doi.org/10.1002/art.10198
  29. Kumari, M. V., M. Hiramatsu, and M. Ebadi. 1998. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic. Res. 29: 93-101 https://doi.org/10.1080/10715769800300111
  30. Lee, E. K., S. M. Kang, D. J. Paik, J. M. Kim, and J. Youn. 2005. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. Int. Immunol. 17: 325-333 https://doi.org/10.1093/intimm/dxh212
  31. Li, X., H. Chen, and P. N. Epstein. 2004. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. J. Biol. Chem. 279: 765-771 https://doi.org/10.1074/jbc.M307907200
  32. Lynes, M. A., C. A. Richardson, R. McCabe, K. C. Crowthers, J. C. Lee, J. Youn, I. B. Schweitzer, and L. D. Shultz. 1999. Metallothionein-mediated alterations in autoimmune disease processes, pp. 437-444. In C. Klaassen (ed.), Metallothionein IV. Basel, Birkhauser
  33. Macian, F., F. Garcia-Cozar, S. H. Im, H. F. Horton, M. C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731 https://doi.org/10.1016/S0092-8674(02)00767-5
  34. Masters, B. A., E. J. Kelly, C. J. Quaife, R. L. Brinster, and R. D. Palmiter. 1994. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl Acad. Sci. USA 91: 584-588
  35. McKim, J. M. Jr., J. Liu, Y. P. Liu, and C. D. Klaassen. 1992. Induction of metallothionein by cadmium-metallothionein in rat liver: A proposed mechanism. Toxicol. Appl. Pharmacol. 112: 318-323 https://doi.org/10.1016/0041-008X(92)90202-4
  36. Miesel, R. and M. Zuber. 1993. Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases. Inflammation 17: 283-294 https://doi.org/10.1007/BF00918991
  37. Mora, A. L., J. Youn, A. D. Keegan, and M. Boothby. 2001. NF-kappaB/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J. Immunol. 166: 2218- 2227 https://doi.org/10.4049/jimmunol.166.4.2218
  38. Morgan, M. E., R. Flierman, L. M. van Duivenvoorde, H. J. Witteveen, W. van Ewijk, J. M. van Laar, R. R. de Vries, and R. E. M. Toes. 2005. Effective treatment of collagen-induced arthritis by adoptive transfer of $CD25^{+}$ regulatory T cells. Arthritis Rheum. 52: 2212-2221 https://doi.org/10.1002/art.21195
  39. Mullen, A. C., F. A. High, A. S. Hutchins, H. W Lee, A. V. Villarino, D. M. Livingston, A. L. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292: 1907-1910 https://doi.org/10.1126/science.1059835
  40. Murata. Y., M. Amao, J. Yoneda, and J. Hamuro. 2002. Intracellular thiol redox status of macrophages directs the Th1 skewing in thioredoxin transgenic mice during aging. Mol. Immunol. 38: 747-757 https://doi.org/10.1016/S0161-5890(01)00111-0
  41. Murata, Y., T. Shimamura, T. Tagami, F. Takatsuki, and J. Hamuro. 2002. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int. Immunopharmacol. 2: 673-689 https://doi.org/10.1016/S1567-5769(01)00212-0
  42. Ohly, P., C. Dohle, J. Abel, J. Seissler, and H. Gleichmann. 2000. Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 43: 1020-1030 https://doi.org/10.1007/s001250050009
  43. Palmiter, R. D., E. P. Sandgren, D. M. Koeller, and R. L. Brinster. 1993. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol. Cell. Biol. 13: 5266-5275 https://doi.org/10.1128/MCB.13.9.5266
  44. Penkowa, M. and J. Hidalgo. 2000. Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis. Glia 32: 247-263 https://doi.org/10.1002/1098-1136(200012)32:3<247::AID-GLIA50>3.0.CO;2-T
  45. Penkowa, M., C. Espejo, E. M. Martinez-Caceres, C. B. Poulsen, X. Montalban, and J. Hidalgo. 2001. Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 119: 248- 260 https://doi.org/10.1016/S0165-5728(01)00357-5
  46. Peterson, J. D., L. A. Herzenberg, K. Vasquez, and C. Waltenbaugh. 1998. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc. Natl. Acad. Sci. USA 95: 3071-3076
  47. Prasad, A. S. 1998. Zinc and immunity. Mol. Cell. Biochem. 188: 63-69 https://doi.org/10.1023/A:1006868305749
  48. Rahman, I., J. Marwick, and P. Kirkham. 2004. Redox modulation of chromatin remodeling: Impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem. Pharmacol. 68: 1255-1267 https://doi.org/10.1016/j.bcp.2004.05.042
  49. Sato, M. and I. Bremner. 1993. Oxygen-free radicals and metallothionein. Free Radic. Biol. Med. 14: 325-337 https://doi.org/10.1016/0891-5849(93)90029-T
  50. Sundstedt, A. and M. Dohlsten. 1998. In vivo anergized $CD4^{+}$ T cells have defective expression and function of the activating protein-1 transcription factor. J. Immunol. 161: 5930-5936
  51. Woo, E. S., Y. Kondo, S. C. Watkins, D. G. Hoyt, and J. S. Lazo. 1996. Nucleophilic distribution of metallothionein in human tumor cells. Exp. Cell Res. 224: 365-371 https://doi.org/10.1006/excr.1996.0146
  52. Yim, S. B. and Y. H. Chung. 2004. Construction and production of concatameric human TNF receptor-immunoglobulin fusion proteins. J. Microbiol. Biotechnol. 14: 81-89
  53. Yin, X., D. A. Knecht, and M. A. Lynes. 2005. Metallothionein mediates leukocyte chemotaxis. BMC Immunol. 6: 21 https://doi.org/10.1186/1471-2172-6-21
  54. Youn, J., S. H. Hwang, Z. Y. Ryoo, M. A. Lynes, D. J. Paik, H. S. Chung, and H. Y. Kim. 2002. Metallothionein suppresses collagen-induced arthritis via induction of TGFbeta and down-regulation of proinflammatory mediators. Clin. Exp. Immunol. 129: 232-239 https://doi.org/10.1046/j.1365-2249.2002.01922.x
  55. Zhang, X., H. Huang, J. Yuan, D. Sun, W. S. Hou, J. Gordon, and J. Xiang. 2005. $CD4^{-}8^{-}$ dendritic cells prime $CD4^{+}$ T regulatory 1 cells to suppress antitumor immunity. J. Immunol. 175: 2931-2937 https://doi.org/10.4049/jimmunol.175.5.2931